Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Cleaver Scientific helps in UK fight against Ebola

Cleaver Scientific reports that its horizontal electrophoresis equipment is being used on the frontline of the UK fight against Ebola.

From Cleaver Scientific Ltd 27 Oct 2014

Encouraging Life science Investment in Northern England

An interview with Dr. Geoff Davison, discussing the major barriers to biomedical investment in the North of England.

27 Oct 2014

NAHQ sponsors National Healthcare Quality Week

National Healthcare Quality Week is sponsored by the National Association for Healthcare Quality. This annual national recognition event brings attention to the profession of healthcare quality and celebrates the work of the individual healthcare quality management professionals who work diligently to enhance the quality of care and optimize patient safety.

27 Oct 2014

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

San Antonio, Texas-based Biotech Company Alpha Diagnostic Int'l has developed and released several convenient, rapid, and sensitive ELISA test kits for the detection of major Ebola viral protein antibodies (Glycoprotein, GP; Nucleoprotein, NP, and Viral Protein 40 or VP40).

23 Oct 2014

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.

21 Oct 2014

Directed Genomics, New England Biolabs to develop new technologies for NGS

New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new technologies for next generation sequencing (NGS), including target enrichment.

From New England Biolabs 20 Oct 2014

RegeneRx to begin RGN-259 Phase 3 trials for treatment of neurotrophic keratopathy

RegeneRx Biopharmaceuticals, Inc. ("the Company" or "RegeneRx") today announced that it met with the FDA in September and as a result of the meeting may begin Phase 3 to evaluate RGN-259 preservative-free eye drops for the treatment of patients with neurotrophic keratopathy (NK), an orphan disease of the cornea.

20 Oct 2014

Twinlab Consolidated Holdings to expand contract manufacturing business

Twinlab Consolidated Holdings, Inc. ("TLCC" or the "Company") announced today that it expects to add more than 20 new American jobs to support its expanding contract manufacturing business.

20 Oct 2014

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

16 Oct 2014

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.

16 Oct 2014

Highland completes US$25 million offering of Class A Common Shares

Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success.

16 Oct 2014

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.

16 Oct 2014

Vanderbilt engineers develop robotic device for less invasive epilepsy surgery

For those most severely affected, treating epilepsy means drilling through the skull deep into the brain to destroy the small area where the seizures originate - invasive, dangerous and with a long recovery period.

16 Oct 2014

GenCell Biosystems acquired by Becton, Dickinson and Company

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.

From BD (Becton, Dickinson and Company) 13 Oct 2014

Deloitte Digital launches Salesforce accelerators for various sectors

Deloitte Digital's newest industry offerings, certified through the Fullforce Initiative as part of the salesforce.com Partner Program, are focused on the health care, insurance, media, and consumer sectors.

13 Oct 2014

First study of promising Ebola vaccine commenced in West Africa

Professor Myron M. Levine, MD, Director of the Center for Vaccine Development at the University of Maryland School of Medicine, and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali and the Ministry of Health of Mali, have begun a clinical trial in health care workers (and other front-line workers) to evaluate a promising experimental Ebola vaccine.

10 Oct 2014

New method can reduce environmental impact caused by manufacturing processes

The human and environmental dangers posed by a widely used manufacturing technique could be almost eradicated thanks to research led by Plymouth University.

9 Oct 2014

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Impax Laboratories, Inc. today announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc. (together, the "Companies") for $700 million in cash, subject to certain customary purchase price adjustments.

9 Oct 2014

Porvair Sciences appoints SPEware Corporation as its exclusive partner

Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation (Baldwin Park, CA) as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems.

From Chromatrap® - Porvair Sciences Ltd 9 Oct 2014

CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

CSL Behring today announced a multi-year, $450 million two-site global capacity expansion – the latest in a series of recent production expansions to meet the growing need for its lifesaving and life-improving therapies that are used to treat patients with rare and serious medical disorders around the world.

8 Oct 2014

Manufacturing News and Research

Further Reading

Cleaver Scientific helps in UK fight against Ebola

Encouraging Life science Investment in Northern England

NAHQ sponsors National Healthcare Quality Week

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

Directed Genomics, New England Biolabs to develop new technologies for NGS

RegeneRx to begin RGN-259 Phase 3 trials for treatment of neurotrophic keratopathy

Twinlab Consolidated Holdings to expand contract manufacturing business

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

Highland completes US$25 million offering of Class A Common Shares

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

Vanderbilt engineers develop robotic device for less invasive epilepsy surgery

GenCell Biosystems acquired by Becton, Dickinson and Company

Deloitte Digital launches Salesforce accelerators for various sectors

First study of promising Ebola vaccine commenced in West Africa

New method can reduce environmental impact caused by manufacturing processes

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Porvair Sciences appoints SPEware Corporation as its exclusive partner

CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News